← Patent-cliff monitor Loss of exclusivity October 2039 latest FDA-listed patent expiry
Drug detail Brand name COBENFY Active ingredient TROSPIUM CHLORIDE; XANOMELINE TARTRATE Strength 20MG;EQ 50MG BASE Dosage form CAPSULE Route ORAL Modality Small molecule FDA approval September 2024 Marketing status RX
Listed patents Patent Expires Type 12558317 October 2039 product 11471413 September 2039 use U-3513 11452692 September 2039 use U-3513 10933020 September 2039 product 11890378 September 2039 product 10925832 September 2039 product 10369143 July 2030 use U-3513 10265311 July 2030 use U-3513 10238643 July 2030 product 10695339 July 2030 use U-3513 10369144 July 2030 product
Regulatory exclusivity Code Expires NCE September 2029
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.